Home › Bristol-Myers wins approval for 1st hepatitis C type 3 drug
 

Keywords :   


Bristol-Myers wins approval for 1st hepatitis C type 3 drug

2015-07-24 22:19:25| Biotech - Topix.net

An experimental drug for one of the most difficult-to-treat types of hepatitis C has been approved by the Food and Drug Administration, adding to the surge of new options for patients with the liver-destroying virus. Daklinza , developed by New York-based Bristol-Myers Squibb Co., is the first drug approved to treat genotype 3 hepatitis C. It's to be used with Sovaldi, one of two blockbuster hepatitis C drugs sold by Gilead Sciences, along with Harvoni.

Tags: type 1st drug approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
03.07Hurricane Beryl Public Advisory Number 19
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Forecast Advisory Number 19
More »